孟德尔遗传
医学
药物基因组学
渗透剂(生化)
疾病
间质性肺病
最先进的
遗传学
肺
基因
病理
生物
生物技术
内科学
数据科学
药理学
计算机科学
作者
Nicole Ng,María Molina‐Molina,Ayodeji Adegunsoye,Raphaël Borie,Chad A. Newton,Benjamin A. Raby,David Zhang,María L. Padilla,Bruno Crestani,Marshall S. Horwitz,Sioḃán Keel,Michael F. Murray,Andrew B. Stergachis,Shandra Lee Knight,Christine Kim Garcia,Louise V. Wain,Ganesh Raghu
出处
期刊:The European respiratory journal
[European Respiratory Society]
日期:2025-08-21
卷期号:66 (3): 2500788-2500788
被引量:9
标识
DOI:10.1183/13993003.00788-2025
摘要
Advancements in genetics and genomics continue to further our understanding of their contributions to the development of interstitial lung diseases (ILDs). This state-of-the-art clinical review synthesises current knowledge of the contribution of genetics when evaluating patients suspected to have ILD. We consider highly penetrant Mendelian disorders as well as common variants conferring smaller risk that act in concert with other genetic and acquired risk factors. Additionally, gene-by-environment and pharmacogenomic interactions are discussed to highlight their impact on disease course. Lastly, the approach to genetic ILDs is reviewed from available testing to future directions.
科研通智能强力驱动
Strongly Powered by AbleSci AI